
Loading, please wait...

Loading, please wait...

TB Mukt Bharat campaign entered a critical new phase following its launch by Union Health Minister J.P. Nadda. This intensified 100-day initiative aims to accelerate India’s progress toward eliminating tuberculosis. Specifically, the program targets 1.58 lakh villages and urban wards across the country. Consequently, the government will use granular micro-plans to ensure precise implementation and measurable health outcomes.
The campaign prioritizes vulnerable populations, including tribal communities, the urban poor, and migrant groups. Furthermore, the initiative bridges last-mile gaps in healthcare delivery. India has already achieved a 21% reduction in TB incidence over the past decade. Therefore, this phase focuses on early detection to maintain this momentum. Additionally, officials highlighted that nearly 50% of TB patients do not present typical symptoms. However, current protocols now address this challenge through comprehensive screening.
To address asymptomatic cases, the program has shifted toward symptom-agnostic screening. Specifically, healthcare workers utilize portable X-rays and AI-enabled diagnostics. The campaign has already screened over 20 crore individuals since December 2024. Consequently, this effort detected 32.65 lakh patients, including 10.9 lakh asymptomatic individuals. Moreover, the BPaLM regimen now reduces treatment for drug-resistant TB from 20 months to just six months. Thus, patient adherence is expected to improve significantly across all states.
Minister Nadda also launched the TB Mukt Bharat App during the national event. This platform features "Khushi," an AI-enabled chatbot that provides real-time guidance on symptoms and diagnostic facilities. Furthermore, the movement has transitioned from a government approach to a whole-of-society movement. Government funding has grown significantly, reaching Rs 6,356 crore in 2025-26. Consequently, these resources drive advancements in research and social support. Community support remains vital to reducing stigma and ensuring treatment completion.
Q1: What is the primary focus of the new 100-day TB Mukt Bharat campaign?
The campaign focuses on intensified screening in 1.58 lakh villages and urban wards. It specifically targets vulnerable groups and uses advanced diagnostics like AI-enabled X-rays to detect asymptomatic cases early.
Q2: How has the treatment for drug-resistant TB changed under this initiative?
India has adopted the BPaLM regimen for drug-resistant tuberculosis. This innovative protocol significantly reduces the treatment duration from 20 months to only six months, which helps in better clinical outcomes and adherence.
Q3: What digital tools were introduced to support TB elimination?
The government launched the TB Mukt Bharat App, which includes a multilingual AI chatbot named Khushi. This tool helps patients find diagnostic facilities and understand their entitlements in real-time.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


India launches an intensified 100-day TB Mukt Bharat campaign focusing on vulnerable groups, asymptomatic screening, and the BPaLM treatment regimen....
6 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today